TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers
TuHURA Biosciences Inc HURA
$2.57
▲ +15.77%
(+$0.35)
Open
$2.28
Prev Close
$2.22
Day Range
$2.26 – $2.58
52W Range
$0.41 – $3.90
Market Cap
$163.66M
Beta
-0.01
EPS (TTM)
$-0.61
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-07-12 |
| Shares Out. | 63,680,000 |
| Website | tuhurabio.com/ ↗ |
| Phone | 18138756600 |
TuHURA Biosciences Inc is a publicly traded company under the ticker symbol HURA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-06-01)